aTyr Pharma

CompanyUnited StatesFounded 2005

Wikidata

aTyr Pharma develops one asset, preclinical (ATYR0101 in fibrosis). Mostly protein or enzyme acting on DARS1; based in the United States, founded in 2005.

1
Asset
Furthest stage
Preclinical
0
Trials
0
Signals

Pipeline

1
  • ATYR0101

    DARS-derived Fc fusion protein

    Preclinical, Protein or enzyme, DARS1, fibrosis

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies6

Intelligence